Estados financieros detallados de Bolt Biotherapeutics, Inc. (BOLT): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Bolt Biotherapeutics, Inc. registró ingresos de $7.7M en el último ejercicio fiscal, con un CAGR de 5 años del 101.6%.
Márgenes de los últimos 12 meses: margen bruto 95.7%, margen operativo -6.2%, margen neto -6.1%.
Al precio actual de $3.63, BOLT presenta beneficios negativos (P/E no significativo) y un ROE del -125.92%. La capitalización bursátil es de $7M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | $215000 | $231000 | $1.3M | $5.7M | $7.9M | $7.7M | $7.7M |
| Coste de Ventas | $302000 | 0 | $40.4M | $75.7M | $73.1M | $61.5M | 0 | $1.5M |
| Beneficio Bruto | -$302000 | $215000 | -$40.1M | -$74.4M | -$67.4M | -$53.7M | $7.7M | $6.2M |
| I+D | $9.4M | $26.0M | $40.4M | $75.7M | $73.1M | $61.5M | $57.5M | $28.5M |
| Generales y Administrativos | $2.2M | $5.2M | $9.1M | $18.4M | $22.9M | $22.5M | $18.5M | $13.8M |
| Gastos Operativos | $11.6M | $31.2M | $9.1M | $18.4M | $22.9M | $22.5M | $80.7M | $40.8M |
| Beneficio Operativo | -$11.6M | -$31.0M | -$49.2M | -$92.8M | -$90.3M | -$76.2M | -$73.0M | -$34.6M |
| EBITDA | -$11.3M | -$30.6M | -$48.6M | -$97.4M | -$86.4M | -$67.3M | -$66.5M | -$31.9M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$11.6M | -$30.5M | -$60.7M | -$98.6M | -$88.1M | -$69.2M | -$63.1M | -$33.4M |
| Impuestos | $40000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$11.6M | -$30.5M | -$60.7M | -$98.6M | -$88.1M | -$69.2M | -$63.1M | -$33.4M |
| BPA | $-5.96 | $-3.75 | $-1.99 | $-2.79 | $-2.30 | $-1.83 | $-1.65 | $-17.85 |
| BPA Diluido | $-5.96 | $-3.75 | $-1.99 | $-2.79 | $-2.30 | $-1.83 | $-1.65 | $-17.85 |
| Acciones en Circulación (Diluidas) | $97186 | $400497 | $1.8M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $13.6M | $34.8M | $5.5M | $27.4M | $9.2M | $10.8M | $7.2M | $11.7M |
| Inversiones a Corto | 0 | 0 | $17.3M | $158.8M | $159.6M | $91.4M | $40.1M | $15.8M |
| Cuentas por Cobrar | 0 | $300000 | 0 | $200000 | 0 | 0 | $1.2M | $973000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $14.1M | $35.9M | $25.4M | $189.2M | $172.7M | $105.7M | $50.8M | $30.3M |
| Inmovilizado Material | $1.4M | $11.5M | $16.4M | $30.6M | $28.5M | $24.1M | $24.9M | $20.5M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $16.0M | $48.4M | $46.5M | $307.7M | $227.8M | $159.8M | $99.6M | $56.7M |
| Cuentas por Pagar | $892000 | $2.1M | $1.6M | $3.6M | $3.6M | $3.0M | $1.5M | $1.4M |
| Deuda a Corto | 0 | 0 | 0 | $2.5M | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $2.8M | $8.7M | $11.3M | $21.3M | $23.1M | $20.5M | $15.9M | $8.4M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $31.9M | $94.3M | $151.5M | $57.6M | $56.3M | $47.0M | $42.4M | $30.2M |
| Reservas | -$17.2M | -$47.7M | -$108.4M | -$207.0M | -$295.1M | -$364.3M | -$427.4M | -$460.8M |
| Patrimonio Neto | -$15.9M | -$45.8M | -$104.9M | $250.1M | $171.5M | $112.7M | $57.2M | $26.5M |
| Deuda Total | $40000 | $10.2M | $10.9M | $24.4M | $22.6M | $20.2M | $25.2M | $23.0M |
| Deuda Neta | -$13.6M | -$24.6M | -$12.0M | -$161.9M | -$146.3M | -$82.0M | -$22.1M | -$4.5M |
| Capital Circulante | $11.3M | $27.2M | $14.1M | $167.8M | $149.6M | $85.3M | $35.0M | $21.8M |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$11.6M | -$30.5M | -$60.7M | -$98.6M | -$88.1M | -$69.2M | -$63.1M | -$33.4M |
| Amortizaciones | $302000 | $335000 | $611000 | $1.2M | $1.7M | $1.9M | $1.8M | $1.3M |
| Compensación en Acciones | $123000 | $508000 | $1.4M | $8.5M | $9.6M | $9.2M | $7.4M | $2.8M |
| Cambio en Capital Circulante | $1.1M | $2.3M | -$2.3M | $20.5M | -$3.1M | -$9.9M | -$8.4M | -$12.1M |
| Flujo de Caja Operativo | -$9.9M | -$26.3M | -$47.3M | -$57.1M | -$76.5M | -$69.5M | -$61.3M | -$39.9M |
| Inversiones (CapEx) | -$290000 | -$508000 | -$3.3M | -$2.3M | -$2.0M | -$206000 | -$41000 | -$72000 |
| Adquisiciones | 0 | 0 | $17.3M | $229.9M | -$59.8M | 0 | $148000 | $963000 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$10.2M | -$26.9M | -$50.6M | -$59.4M | -$78.5M | -$69.7M | -$61.3M | -$39.9M |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +7.4% | +445.5% | +354.7% | +37.5% | -2.4% | +0.1% | ||
| Crecimiento Beneficio Neto (anual) | -163.1% | -99.2% | -62.3% | +10.6% | +21.5% | +8.8% | +47.1% | |
| Crecimiento BPA (anual) | +37.1% | +46.9% | -40.2% | +17.6% | +20.4% | +9.8% | -981.8% | |
| Cambio en Acciones (anual) | +312.1% | +352.5% | +3.2% | -0.1% | +1.2% | +1.0% | -2.1% | |
| Crecimiento FCF (anual) | -164.2% | -88.3% | -17.5% | -32.1% | +11.1% | +12.0% | +34.9% | |
| Margen Bruto | 100.0% | -17370.6% | -5904.4% | -1176.4% | -681.4% | 100.0% | 80.6% | |
| Margen Operativo | -14404.2% | -21290.9% | -7364.1% | -1576.6% | -967.4% | -949.9% | -450.1% | |
| Margen EBITDA | -14248.4% | -21026.4% | -7730.0% | -1508.7% | -855.0% | -864.2% | -414.4% | |
| Margen Neto | -14180.0% | -26289.2% | -7824.7% | -1537.8% | -878.6% | -820.8% | -433.7% | |
| Margen FCF | -12488.8% | -21891.8% | -4714.6% | -1369.5% | -885.4% | -797.5% | -518.8% | |
| Tasa Impositiva Efectiva | -0.3% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-104.56 | $-67.04 | $-27.90 | $-31.77 | $-42.00 | $-36.88 | $-32.12 | $-21.35 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $97186 | $400497 | $1.8M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -125.92% |
| Rentabilidad sobre capital invertido | -67.72% |
| Rentabilidad sobre activos | -58.81% |
| Margen bruto | 95.68% |
| Margen operativo | -623.04% |
| Margen neto | -611.47% |
Salud financiera
| Deuda / Patrimonio | 1.71 |
| Ratio corriente | 2.61 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -12.58 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| P/E | -107.89 | -171.47 | -323.12 | -35.13 | -11.30 | -12.24 | -6.48 | -0.31 |
| P/VC | -3.92 | -5.62 | -11.10 | 0.73 | 0.28 | 0.38 | 0.36 | 0.39 |
| P/V | 0.00 | 1197.77 | 5044.73 | 145.44 | 8.48 | 5.38 | 2.66 | 1.33 |
| Margen Bruto | 0.0% | 100.0% | -17370.6% | -5904.4% | -1176.4% | -681.4% | 100.0% | 80.6% |
| Margen Operativo | 0.0% | -14404.2% | -21290.9% | -7364.1% | -1576.6% | -967.4% | -949.9% | -450.1% |
| Margen Neto | 0.0% | -14180.0% | -26289.2% | -7824.7% | -1537.8% | -878.6% | -820.8% | -433.7% |
Empresas relacionadas: AEON · CING · CLRB · EVGN · IMNN · INAB · LYRA
Explorar sector: Healthcare · Biotechnology
Más secciones de BOLT: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones